Future Unicorns
- Home
- Information Center
- Future Unicorns

About the company
Background
About the product and/or technology

- Learned the big data of a wide range of disease encompassing more than 200,000 cases.
- Real-time confirmation, analysis and diagnosis of endoscopic image frames
- Real-time marking and examination guidance of suspected lesions
- Marking of examined and unexamined areas during endoscopy
- Identification and diagnosis of lesions with a sensitivity of 90 percent and accuracy of 93 percent.
Alphaon, a diagnostic devise detecting digestive diseases and cancer
- Real-time interoperability with various endoscopy systems
- Touch switches with AI operation, sensitivity adjustment, examination area setting, video recording and backup features for hassle-free endoscopy
- Accurate detection and diagnosis of tumors and inflammation inside the digestive system
- Capability and confidence of medical personnel enhanced with excellent lesion detection
Competitive edge and business strategy
- Attracted investments worth KRW 1.1 billion as of April 2022
- Conducting two government R&D projects in 2022 (worth KRW 0.22 billion)
- Registration and application of more than twenty patents at home and overseas
- Selected as a K-Biohealth Business, an ITP Boost Startup, a Shinhan S2 Bridge Leading Startup, and as one of Korea Credit Guarantee Fund’s OPEN NETS 200 Businesses
- Signing of MOU for AI Medical Device R&D and Demonstration with Gachon University Gil Medical Center and Korea University Medical Center in 2022
Future plans
- October 2022: Demonstration of AI medical device Alphaon with Gachon University Gil Medical Center
- November 2022: Demonstration of Alphaon with Gachon University Gil Medical Center
- November 2022: Series A round for production and overseas market exploration
- December 2022: Approval of the AI medical device by the Ministry of Food and Drug Safety (Grade 2)
- January 2023: GMP certification for the manufacturing of medical devices
- February 2023: TIPS program application and selection
- February 2023: Establishment of a joint venture and entering the UAE market with Alphaon
- June 2023: Establishment of a joint venture and entering the Korean and UAE markets with Alphaon
- July 2023: Development of Alphaon (diagnosis of colon diseases)
- January 2024: Development of Alphaon (diagnosis of liver diseases)
- March 2024: Launch of Alphaon (remote consultation and cloud service)
- January 2024: Launch of a platform providing medical data analysis, interpretation and diagnosis services